DOCK4 and ovarian carcinoma: Meanwhile, our results suggest that DOCK4, a Rho GTPase exchange factor for Rac, is negatively correlated with the survival of ovarian cancer patients, supporting previous reports that the abnormal expression of DOCK4 has been associated with tumor migration and metastasis in breast cancer and lung adenocarcinoma [21, 22].